Skip to main content
. 2020 Jun 26;11:501. doi: 10.3389/fneur.2020.00501

Figure 1.

Figure 1

Map showing population-based prevalence studies of NMOSD around the world. There were eight studies in Europe, 10 in Asia, one in Oceania, and two in the Americas (one in Cuba and one joint study in the USA and Martinique Island). Numbers given were prevalence per 100,000 population. In certain studies, the prevalence according to racial groups was given. Adults, only adult population was studied.